p53 plays a central role in the maintenance of the genome integrity, both as a gatekeeper and a caretaker. Sequencespecific recognition of DNA is underlying the ability of p53 to transcriptionally transactivate target genes during checkpoint control and to regulate DNA replication at the TGCCT repeat from the ribosomal gene cluster (RGC). In contrast, suppression of recombination by p53 has been observed with nonconsensus DNA sequences. In this study, we discovered that wild-type p53 stimulates homologous recombination adjacent to the RGC repeat, whereas downregulation is seen with a mutated version thereof and with a microsatellite repeat sequence. Analysis of the causes possibly underlying the enhancement of homologous recombination revealed that p53 binding to the RGC element delays DNA synthesis. This was demonstrated after integration of the corresponding DNA fragments into our Simian virus 40-based model system, which was used to study recombination on replicating minichromosomes. Differently, with plasmid-based substrates, p53 did not stimulate recombination at the RGC sequence. Thus, in combination with our previous findings, p53 may promote homologous recombination by two separate mechanisms involving either molecular interactions with topoisomerase I or/and by specific binding to certain genomic regions, thereby causing replication fork stalling and recombination.
Introduction
The capacity of wild-type p53 (wtp53) to bind certain DNA structures plays a crucial role in the execution and coordination of its tumor suppressor activities. Sequence-dependent interactions mediate transcriptional transactivation of growth regulatory, proapoptotic, and antiangiogenic target genes (Vogelstein et al., 2000) . Additionally, p53 nonsequence-specifically binds DNA, namely DNA mismatches and Holliday junctions, and this activity has been proposed to mediate functions in DNA repair and/or in proofreading DNA replication (Albrechtsen et al., 1999) . Thus, p53 recognizes free DNA ends and mispairings, reanneals short stretches of unpaired strands, and exonucleolytically degrades nonconsensus sequence DNA. Moreover, wtp53 strongly interacts with recombination intermediates, in which the strand crossing represents the critical determinant for high-affinity binding . DNA junction binding in particular has been connected to a possible role of wtp53 in the inhibition of gene conversion events (Dudenho¨ffer et al., 1998; Akyu¨z et al., 2002) , and, more recently, of replication-associated recombination processes Saintigny and Lopez, 2002) . In further support for an antirecombinogenic role of p53 in a DNA sequence-independent manner, p53 was shown to inhibit strand exchange promoted by Rad51 on randomly chosen DNA substrates (Yoon et al., 2004) and to downregulate recombination with different sequences (Boehden et al., 2004) . Finally, on the basis of recombination measurements with p53 mutants, it was demonstrated that transcriptional transactivation, which relies on sequence-specific DNA recognition, and consensus sequence-independent downregulation of recombination are genetically separable functions of p53 (Dudenho¨ffer et al., 1999; Saintigny et al., 1999; Willers et al., 2000; Akyu¨z et al., 2002) . However, recently published data challenged the notion that p53 regulates homologous recombination in a negative and sequence-independent manner exclusively (Boehden et al., 2004) . Thus, when analysing the role of p53 in recombination involving leukemia-related sequences, wtp53 displayed a stimulatory activity directed toward a fragment from the RARa breakpoint cluster region (bcr).
To understand whether binding of p53 to a consensus sequence influences its regulatory functions in recombination, we examined homologous recombination with DNA substrates comprising either the p53-specific RGC recognition sequence or control sequences. We introduced the corresponding DNA fragments into our Simian virus 40 (SV40)-based (Wiesmu¨ller et al., 1996) and fluorescence-based assays (Akyu¨z et al., 2002) and measured recombination in isogenic cells differing in their p53 status.
Results
Homologous recombination between SV40 chromosomes as a function of RGC, RGC mutated, and triplet repeat sequences
To investigate a sequence-specific role for wtp53 in DNA recombination, we adapted our SV40-based recombination assay to the analysis of a p53-binding site and control sequences. The recombination test system relies on efficient gene transfer by viral infection and subsequent genetic exchange between differently mutated, temperature-sensitive (ts) SV40 variants (Wiesmu¨ller et al., 1996) . After virus production at the permissive temperature of 321C, the cells of interest were doubly infected with two ts-SV40 mutants at 391C (Figure 1a) . Subsequently, the release of wild-type (wtVP1) virus particles was scored by reinfection and plaque assays at 391C. The recombination frequency was calculated from the plaque forming units (PFUs) counted after coinfection experiments and was normalized for the plaque formation after SV40-wtVP1 infection. For the insertion of the RGC and other sequences of similar length, we utilized shortened variants of the SV40-wtVP1, SV40-tsVP1(196Y), and SV40-tsVP1(290T) genomes with unique restriction sites Figure 1 Testing homologous recombination with SV40 chromosomes comprising the RGC, the RGC mutated, or the CTG98 repeat DNA sequences. (a) Assay principle. SV40-tsVP1(196Y), SV40-tsVP1(290T), and SV40-wtVP1 genomes were engineered such that foreign DNA sequences were located between early and late viral sequences, as detailed in panel b. Following transfection and virus amplification at 321C, recombination assays were performed at 391C by doubly infecting cells with SV40-tsVP1(196Y) and SV40-tsVP1(290T) particles. Reconstitution of SV40-wtVP1 viruses by homologous recombination was scored by reinfection and plaque assays at 391C. Recombination frequencies were calculated from PFUs after coinfection versus SV40-wtVP1 infection. (b) SV40 genome design. In order to permit packaging of additional DNA pieces, 269 bp from the large tumor antigen (Tag) intron within the SV40-tsVP1 and the SV40-wtVP1 genomes were removed (Boehden et al., 2004) . The polyadenylation signals from the early (TagPolyA) and the late coding region (PolyA-VP1) were separated by PCR cloning, which concomitantly inserted two new restriction sites (Cla linker). Into the Cla linker of the resulting SV40-tsVP1(196Y)-Cla, SV40-tsVP1(290T)-Cla, and SV40-wtVP1-Cla genomes, we introduced the RGC, the RGC mutated, and the CTG98 repeats as indicated. (c) Homologous recombination in LLC-MK 2 (neo) cells. Recombination assays were performed using SV40-tsVP1(196Y), SV40-tsVP1(290T), and SV40-wtVP1 (wild-type virus set) and different derivatives comprising the indicated foreign DNA sequences. The size of each nonviral DNA sequence including the flanking cloning sites is given in bp. Recombination frequencies including s.e.m. were determined in two independent LLC-MK 2 (neo) cell clones with 2-12 independent quadruplicate measurements per clone. The ratio of the recombination frequency for a virus containing a foreign DNA element versus that for the wild-type virus was calculated p53 recognition sequence in recombination GS Boehden et al neighboring the indicator mutations (Boehden et al., 2004; Figure 1b) . According to this SV40 genome design, all foreign sequences were localized between the transcribed regions diametrically opposed to the origin of bidirectional replication. Thus, orientationdependent effects of the inserts relative to the replication origin of replication could be excluded. In our previous study, we also made sure that genome alterations, introduced to permit packaging of additional pieces of DNA, did not affect homologous recombination in the SV40-based recombination assay, as demonstrated after insertion of a control sequence of 0.3 kb (Boehden et al., 2004) . First, we introduced a well-characterized DNA fragment consisting of 13 copies of the 19 bp RGC motif into the unique ClaI restriction site of all three SV40 genomes, that is, of SV40-wtVP1, , and SV40-tsVP1(290T) Farmer et al., 1992; Figure 1b) . Second, we inserted 15 copies of a mutated RGC, which was shown not to be recognized by wtp53. The orientation of the RGC and the mutated RGC motif was the same within all three SV40 genomes. Third, to challenge a potential recombination regulatory role of p53 directed toward repetitive DNA sequences in general (Ahrendt et al., 2000; Gebow et al., 2000; Danaee et al., 2002; Toft et al., 2002) , we inserted a triplet repeat consisting of 98 CTG copies that causes enhancement of intermolecular recombination in an Escherichia coli plasmid system (Bowater et al., 1996; Pluciennik et al., 2002) .
To analyse p53-independent influences of the SV40 genome alterations on interchromosomal exchanges, we measured recombination in the primate cell line LLC-MK 2 (Wiesmu¨ller et al., 1996) according to the strategy depicted in Figure 1a . LLC-MK 2 cells endogenously express p53(D237-239), which displays a Pab240 reactive conformation and does not perform transcriptional transactivation, cell cycle control, or recombination regulatory activities (Dudenho¨ffer et al., 1998) . As reported previously, the wild-type virus set promoted recombination at an average frequency of 1 Â 10 À3 (Boehden et al., 2004) . The RGC and RGC mutated elements caused a 4.6-fold increase and the (CTG) 98 repeat a threefold increase in the basal frequency of interchromosomal homologous recombination ( Figure 1c) .
Recombination between SV40 chromosomes in LLC-MK 2 cells expressing wtp53 and p53(138V): stimulation at the RGC recognition sequence
Having established the influence of the DNA sequences of interest on homologous recombination in the absence of wtp53, we measured recombination with the same parental line in the presence of wtp53. For this purpose, we made use of fresh LLC-MK 2 cell clones ectopically expressing human wtp53 C-terminally fused to the human estrogen receptor hormone-binding domain (p53her), which allows to activate wtp53 functions after 17b-estradiol application (Dudenho¨ffer et al., 1998 (Dudenho¨ffer et al., , 1999 Boehden et al., 2004) . In our preceding studies, we demonstrated that p53her displays transcriptional transactivation via the RGC element in LLC-MK 2 cells (Dudenho¨ffer et al., 1999) and similarly downregulates recombination in LLC-MK 2 cells and in the p53-negative line KMV (Akyu¨z et al., 2002) . Importantly, within this chimera, the C-terminal oligomerization domain of p53 is not accessible before hormone binding by the her-fusion, thereby diminishing inactivating effects on p53her via hetero-oligomerization with endogenous mutant p53(D237-239) or via complex formation with large T antigen. In our present study, we also assayed newly established LLC-MK 2 cell clones that stably express the mutant p53(138V)her. p53(138V) and its murine counterpart p53(135V) belong to the class of conformationally altered p53 mutants that are defective in sequence-specific DNA binding and transcriptional transactivation but have retained the capacity to suppress homologous recombination (Xiao et al., 1998; Willers et al., 2000; Akyu¨z et al., 2002) .
Expression of the exogenous proteins was checked by Western blotting using the monoclonal antibody DO1 ( Figure 2a ). Next, we determined the consequences of p53her and p53(138V)her protein expression on cell growth in the stably transfected clones (Figure 2c ). The lines expressing p53her had an increased generation time already in the absence of estradiol, consistent with partial activation of p53 fusion protein by residual amounts of estradiol-like substances in the stripped media (Dudenho¨ffer et al., 1998) . Estradiol addition was followed by a further growth delay, reflecting the fully activated state of p53her in these cells. However, none of the two p53(138V)her mutant lines exhibited growth retardation, either with or without estradiol. Transcriptional transactivation of the endogenous target gene waf1/cip1/p21 was assessed by Western blot analysis of p21 protein expression, confirming the defect in p53(138V) versus wtp53 ( Figure 2b ). Consistently, we noticed reduced DNA-binding activities for p53(138V)her as compared to p53her in electrophoretic mobility shift assays ( Figure 2d ). Thus, as expected, the p53 mutation 138V affected the DNA-binding, transactivation, and growth regulatory activities of the hybrid protein.
To examine the effect of wtp53 on recombination with SV40 chromosomes carrying the indicated DNA sequences, we subjected four LLC-MK 2 (p53her) and two LLC-MK 2 [p53(138V)her] cell lines to the recombination assays outlined above. As previously seen, wtp53 downregulated homologous recombination with the majority of sequences analysed (Boehden et al., 2004) . Thus, when comparing the recombination frequencies in LLC-MK 2 (p53her) and LLC-MK 2 (neo) clones, we measured an average decrease by fourfold with the wild-type virus set, and by 2-3-fold after coinfections with RGC mutated and CTG98 viruses ( . Surprisingly, however, in the experiments with RGC virus, recombination was stimulated 4-5-fold by p53her expression and twofold in the presence of p53(138V)her ( Figure 3 ). Therefore, recombination was suppressed to a similar extent by both wtp53 and p53(138V), whereas recombination enhancement at RGC sequences was twofold less pronounced with p53(138V) as compared with wtp53 (P ¼ 0.036).
Effect of the RGC element on DNA replication
Our SV40-based assay has previously been used to study recombination linked to replication fork stalling, a repair process that is effectively controlled by wtp53 Saintigny and Lopez, 2002) . To test the possibility that changes in DNA replication activities may underlie the stimulatory effect of wtp53 on homologous recombination with RGC virus genomes, we determined de novo viral DNA synthesis at different times after infection (hpi) with respect to the selected DNA sequences (Figure 4 ). The corresponding data were compared to the replication kinetics of wild-type SV40 that have been described previously (Janz and Wiesmu¨l-ler, 2002; Boehden et al., 2004) . After infecting LLC-MK 2 (neo) cells with RGC virus, a similar replication pattern was seen as with the RGC mutated and the wild-type virus. With CTG98 viruses, we observed a modest, namely an approximately 1.5-fold increase of the maximum [ 3 H]thymidine incorporation. Replication peaked at 12-24 hpi in LLC-MK 2 (neo) cells with all virus types and in LLC-MK 2 (p53her) cells with all non-RGC viruses. In LLC-MK 2 (p53her) cells, no significant differences were found between the extent of de novo DNA synthesis for the wild-type, CTG98, and RGC mutated virus genomes. Interestingly, however, RGC virus genomes were replicated with a delayed peak at 36 hpi. Taken together, our experiments unveiled a wtp53-dependent retardation of viral DNA synthesis involving multiple copies of the p53-binding site from the RGC. Thus, the incorporation of a sequence, which is specifically recognized by wtp53, altered both viral replication and interchromosomal recombination in a wtp53-dependent manner.
wtp53 does not stimulate recombination at the RGC recognition sequence in a plasmid-based test system
To clarify the role of replication modulation in p53-mediated recombination stimulation at the RGC sequence, we applied a nonreplicating recombination substrate. For this purpose, we modified our EGFPbased assay (Akyu¨z et al., 2002) such that the (138V)her. Radioactively labeled DNA fragments (RGC, CTG98) were prepared by PCR, purified, and subjected to electrophoretic mobility shift assays. Nuclear extracts from p53-negative KMV cells transfected with pSVp53her (wt), pSV53(138V)her (138), or pBS (À) were mixed with either BSA or specific antibody DO1 and incubated on ice for 30 min. Subsequently, the DNA substrates were added, followed by a 30 min incubation at 391C and electrophoresis on a 4% polyacrylamide gel. Due to an unusual migration behavior in the gel, RGC mutated DNA could not be employed to compare binding. The positions in the autoradiograph of the free probes and of the p53-DNA complexes are indicated. Note that DO1 stimulates RGC binding by p53her and to a lesser degree also by p53(138V)her recombination plasmids carry the RGC-binding site or its mutated version between two differently mutated EGFP genes (HR-EGFP and 3 0 EGFP; Figure 5a ). Homologous recombination between HR-EGFP and 3 0 EGFP may restore a functional EGFP gene and give rise to green fluorescent cells. To quantify recombination frequencies, the ratios between green fluorescent cells and the total number of cells in the population was determined by flow cytometry. In order to exclude rate deviations caused by growth regulatory effects with the individual cell type used, a cotransfection with a control plasmid carrying a wild-type copy of EGFP at the HR-EGFP position was performed in parallel with each recombination experiment and was used to normalize recombination frequencies.
Homologous recombination was studied by concomitantly introducing the recombination plasmid and the p53her expression vector pSV53her or pBS into the p53-negative, K562-derived cell line KMV and by performing FACS s analysis 48 h later. As seen previously with other spacer sequences (Akyu¨z et al., 2002) , pSV53her coelectroporated cells showed recombination frequencies that were reduced as compared to the pBS-transfected control cells (Figure 5b) . Here, recombination at an SV40-derived control fragment decreased by 44 and 13-26% at the RGC and the RGC mutated sequence, independently of the orientation within the recombination vector. Similarly, in LLC-MK 2 (neo) and LLC-MK 2 (p53her) cells, we did not detect a p53her-mediated recombination stimulation involving the RGC sequence, when using the EGFP-based assay (data not shown). Thus, with nonreplicating recombination substrates, a p53-dependent stimulation of recombination at the specific RGC recognition sequence was not observed.
Discussion
p53 stimulates recombination at the RGC repeat Wtp53 has been described to recognize B70 sequences within the human genome in a sequence-dependent manner, and most of the p53-binding sequences play an essential role in the transcriptional activation of growth regulatory and proapoptotic target genes (Vogelstein et al., 2000; Jeffers et al., 2003) . Additionally, recognition sequences of wtp53 were identified that are not connected to transactivating functions, but are related to replication origins, such as the TGCCT repeats Figure 1c for the absolute values), and the relative recombination frequencies were calculated. Values are the mean7s.e.m. values from four p53her (wtp53) and two p53(138V)her clones, each analysed by two to six independent quadruplicate measurements Figure 4 Effect of the RGC, the RGC mutated, and the CTG98 repeat DNA sequences on viral replication. De novo viral DNA synthesis was analysed in LLC-MK 2 (neo) (black rhombus) and LLC-MK 2 (p53her) (gray squares) cells after infection with wildtype virus (see Boehden et al., 2004) (Bargonetti et al., 1991; Kern et al., 1991 Kern et al., , 1992 . Accumulating evidence also indicates that p53 is directly involved in the downregulation of homologous recombination (Dudenho¨ffer et al., 1999; Saintigny et al., 1999; Willers et al., 2000) , particularly of replication-associated events Saintigny and Lopez, 2002) . In the present study, we characterized the RGC p53-binding sequence with respect to a potential influence on the regulatory functions of p53 in homologous recombination. For this purpose, we applied a recombination assay based on SV40 minichromosomes that has previously been exploited as a powerful tool to examine the role of specific DNA sequences in DNA replication or recombination (Ariizumi et al., 1993; Miller et al., 1995; Boehden et al., 2004) . In contrast with the welldescribed antirecombinogenic effect of p53 on homologous recombination, we saw an average 4-5-fold upregulation of recombination adjacent to the inserted RGC element in the different clones carrying wtp53. Clearly, the striking difference between the results obtained with RGC and its mutated version indicated that stable complex formation between p53 and its binding sequence RGC is the critical determinant of this effect Farmer et al., 1992) . Consistent with this, the transactivation-and DNAbinding-defective mutant p53(138V) was significantly less stimulatory than wtp53. p53 does not stimulate recombination at the (CTG) 98 repeat p53 has been linked to repeat sequences in several ways: p53 directly binds and activates the PIG3 promoter through a pentanucleotide microsatellite sequence with limited similarity to the p53 consensus sequence (Contente et al., 2002) . Moreover, microsatellite instabilities at tetranucleotide repeats were found to be associated with p53 mutations in skin, bladder, and lung cancer (Ahrendt et al., 2000; Danaee et al., 2002) . Finally, on the basis of examinations in thymic lymphomas from MSH2/p53 intercrossed mice, it was proposed that p53 modulates microsatellite instabilities and becomes essential to this process after loss of MSH2 (Toft et al., 2002) . In this study, a threefold recombination enhancement was conferred by the (CTG) 98 microsatellite repeat in the parental line without wtp53, which is consistent with previous studies that suggested that homologous recombination is the mechanism underlying instabilities at this triplet repeat within the myotonic dystrophy locus (Richard and Paques, 2000) . Exogenously expressed wtp53 exhibited an antirecombinogenic effect on the (CTG) 98 -induced exchanges. This result is in agreement with a previous study on the p53-dependent inhibition of deletion events between Alu repeats (Gebow et al., 2000) , and shows that the (CTG) 98 microsatellite repeat is regulated differently as compared to the RGC repeat. Consistently, the (CTG) 98 fragment was not stably complexed by wtp53 in gel shift experiments, whereas the RGC element was confirmed to be bound by wtp53. The degree of recombination (Akyu¨z et al., 2002) contains the HR-EGFP gene, which is mutated within the chromophore coding region (black triangle) and under the control of a CMV promoter, and the 3 0 EGFP donor gene, which carries two truncating stop codons in place of the start codon (black cross). Within the spacer region, the RGC repeat p53-binding site (0.3 kb) and the RGC mutated repeat (0.3 kb) were introduced in the forward and the reverse orientation. The consensus decamer is shown with small letters indicating deviations from the consensus sequence (El-Deiry et al., 1992) . The 0.4 kb SV40-derived DNA sequence covering the recombination marker in the virus-based test system was inserted as a control (see Figure 1b) . (b) Recombination in KMV cells in the absence or presence of p53. Recombination assays were performed by electroporating KMV cells with recombination plasmids carrying the indicated inserts. For expression of p53her, we coelectroporated the cells with plasmid pSV53her (wtp53). The control cells received pBS instead. Recombination frequencies were determined from the fraction of green fluorescent cells 48 h after transfection. Recombination frequencies in pBS-transfected cells were taken as 100% (3.6 Â 10 À2 for SV40, 4.5 Â 10 À2 for RGC forward, 2.5 Â 10 À2 for RGC reverse, 4.8 Â 10 À2 for RGC mutated forward, 4.1 Â 10 À2 for RGC mutated reverse) and the relative recombination frequencies calculated. Mean and s.e.m. values from nine measurements obtained in three independent experiments are given p53 recognition sequence in recombination GS Boehden et al downregulation by wtp53 was very similar for the CTG98 virus and the wild-type control, namely 3-4-fold. This finding argues against a p53-dependent inhibitory mechanism, which is specific for repetitive DNA structures, such as an interference with the formation of slipped strand structures by p53.
Possible mechanisms underlying recombination stimulation at the RGC
In our latest study, we made the surprising finding that p53 stimulates recombination adjacent to a DNA sequence taken from the RARa bcr (Boehden et al., 2004) . Subsequent measurements with the topoisomerase I stabilizing drug camptothecin indicated that activation of topoisomerase I is underlying this recombination enhancement by p53. This finding converged with biochemical studies demonstrating that p53 promotes a recombination-like reaction that relies on topoisomerase I cleavage complexes (Stephan et al., 2002) . However, unlike the RARa fragment, the RGC repeat does not comprise a perfect topoisomerase I recognition site (Jaxel et al., 1988; Tsui et al., 1989) . Thus, in the case of the RGC repeat, the recruitment of wtp53 by topoisomerase I is unlikely to represent the initial cause of recombination enhancement by wtp53. Consistently, when we treated RGC virus-infected LLC-MK 2 (neo) and LLC-MK 2 (p53her) cells with camptothecin, we noticed the reconstitution of the recombination inhibitory effect of wtp53 at the RGC recognition sequence (data not shown), whereas with RARa bcr virus, the same wtp53-specific recombination increase was monitored with and without camptothecin treatment (Boehden et al., 2004) . This suggested that p53 stimulates recombination at the RGC element by a mechanism different from the topoisomerase I-based pathway with the RARa sequence.
In an earlier study, RGC repeats were shown to stimulate replication of a polyoma virus-based episome in a p53-dependent manner (Kanda et al., 1994) . Somewhat contradictorily, Miller et al. (1995) reported that wtp53 inhibited polyoma virus DNA replication in a sequence-dependent manner. Here, we observed a delay of the DNA synthesis peak by wtp53. A correlation could be drawn between specific DNA binding by p53 and replication retardation, since it was specific for the RGC as compared to the RGC mutated or the (CTG) 98 repeat. It is well established that replication fork pausing leads to elevated recombination activities (Flores-Rozas and Kolodner, 2000; Saintigny et al., 2001) , so that in this case of p53-mediated recombination stimulation, that is, with a p53-binding sequence, the two phenomena seem to be mechanistically linked. In confirmation of this interpretation, we did not observe RGC-specific recombination stimulation by p53 with nonreplicating recombination substrates. Nevertheless, this mechanism is not applicable to explain a recombination frequency increase in response to wtp53 expression in general, because the replication curve for the RARa bcr virus is indistinguishable from control curves (Boehden et al., 2004) .
Again, this indicates that the underlying mechanisms for recombination stimulation at the RGC and the RARa bcr differ.
Notably, from their data, Brazdova et al. (2002) concluded that oligomeric p53 forms filaments on supercoiled DNA. From this, it is conceivable that oligomeric p53, tightly bound to the RGC repeat, represents an obstacle to fork progression during SV40 minichromosome replication, thereby triggering strand exchange. Thus, although recombination induced by replication arrest after aphidicolin or hydroxyurea treatment is inhibited by p53 Saintigny and Lopez, 2002) , p53, when sequence-specifically bound to DNA, transiently blocks replication and stimulates rather than suppresses recombination. One possible explanation for this apparently conflicting role of p53 is that upon replication pausing in the absence of DNA breakage, p53 will not or only partially be relocalized from the consensus binding to the recombination site. Thus, a stalled replication fork alone may be insufficient to induce the recombination inhibitory activity of p53, as was proposed for the induction of the SOS response in E. coli (Rothstein et al., 2000) . In agreement with this idea, we noticed that p53 regained recombination inhibitory activities at the RGC-binding site upon camptothecinmediated DNA breakage (not shown). Interestingly, the DNA-dependent protein kinase was proposed to form a sensor complex together with p53 in response to nucleoside analog treatment and, therefore, represents a candidate that may recruit p53 to the replication fork in a damage-specific manner (Achanta et al., 2001) . Additionally, the Bloom's syndrome protein (BLM), a RecQ helicase that branch migrates Holliday junctions, has been reported to transport p53 to sites of stalled forks after hydroxyurea treatment, which produces double-stranded DNA break (Saintigny et al., 2001; Sengupta et al., 2003) . Therefore, it will be interesting to see whether recombination initiated by an elongation inhibitor versus p53 bound to the consensus site differs with respect to the appearance and the composition of surveillance complexes.
At present, we do not know whether binding of p53 to the RGC in the human genome is related to ribosomal DNA synthesis at a neighboring replication origin or to the amplification of ribosomal DNA repeats. However, our results are highly reminiscent of a series of data from yeast, in which the Fob1 protein is required for site-specific DNA replication fork blocking and recombination stimulation in the rRNA gene cluster on the Saccharomyces cerevisiae chromosome XII (Kobayashi and Horiuchi, 1996) . In this system, Fob1 activities appear to be essential in rDNA expansion and contraction, while RNA polymerase I controls repeat numbers (Kobayashi et al., 1998) . Similar mechanisms may exist in human cells, in which the transcription terminator factor I inhibits RNA polymerase I-dependent transcription and mediates replication fork arrest sequence-specifically at the 3 0 end of the rRNA transcription unit (Gerber et al., 1997) . Remarkably, p53, like Fob1 (Defossez et al., 1999) , is localized to the p53 recognition sequence in recombination GS Boehden et al nucleolus, interacts with SL1, an auxiliary factor of RNA polymerase I, and suppresses RNA polymerase I transcription (Zhai and Comai, 2000; Rubbi and Milner, 2003) . Thus, in analogy to the data from yeast, a possible role for p53-induced recombination at the RGC-binding site is rDNA copy number adjustment and sequence homogenization.
Conclusions
Taken together, we discovered that wtp53 upregulates recombination at the RGC repeat, a specific binding sequence of p53. Conversely, we did not find any indication for a role of wtp53 in regulating recombination at the mutated RGC repeat or at a CTG microsatellite sequence. Different from the stimulatory mechanism strictly involving topoisomerase I, here, a rise in the local p53 concentration and a delay of replication fork progression is likely to promote replication-associated recombination. From these data, we speculate that p53 performs caretaker functions by global suppression of mutagenic DNA exchange events, by stimulatory interactions with topoisomerase I at specific DNA lesions, and by promoting directed recombinogenic events to maintain rDNA sequence homogeneity.
Materials and methods

DNA manipulations
The RGC and RGC mutated repeats were transferred after SmaI/HincII excision from pSK-45-13-2-PyCAT and pSK-89-15-1-PyCAT to the unique SmaI site within pUC-SV40-Cla, pUC-SV40-tsVP1(196Y)-Cla, and pUC-SV40-tsVP1(290T)-Cla (Boehden et al., 2004; Figure 1b) , and the (CTG) 98 repeat (Bowater et al., 1996; Pluciennik et al., 2002) was cloned after EcoRI/HindIII digestion of pRW3246 and blunt end formation. Each vector set carried the foreign sequence in the same orientation, and nonviral inserts were verified by sequencing on an ABi 377 sequencer.
To introduce p53-binding sites and control sequences into the HR-EGFP/3 0 EGFP vector for fluorescence-based recombination analysis (Akyu¨z et al., 2002) , we utilized the SalI site between the HR-EGFP acceptor and the 3 0 EGFP donor gene ( Figure 5 ). The SmaI/HincII fragments comprising the RGC and RGC mutated repeats (0.3 kb) were each cloned in both orientations. The XcmI/BamHI fragment from wild-type SV40 DNA (0.4 kb) was inserted as an additional spacer control.
Establishment and growth of cell lines
CV1 kidney cells from African green monkey, the SV40 large tumor antigen-transformed derivative COS1, and the LLC-MK 2 line from rhesus monkey kidney were grown in DMEM supplemented with 10% FCS at 371C (Wiesmu¨ller et al., 1996) . KMV cells derived from the human myeloid leukemia cell line K562 were grown in RPMI medium supplemented with 12% FCS (Akyu¨z et al., 2002) . LLC-MK 2 (p53her), LLC-MK 2 [p53(138V)her], and LLC-MK 2 (neo) cells were established after calcium phosphate-mediated transfection of LLC-MK 2 cells with pSV53her plus pM5neo, pSVp53(138V)her plus pM5neo, and pM5neo, respectively. Clones were cultivated in phenol red-free DMEM supplemented with charcoalstripped 10% FCS. Antibiotic selection was achieved by the addition of 0.8 mg/ml G418 (Invitrogen). Isolated clones were tested for transgene expression by immunoblotting. In all, 10-20% were identified as p53(138V)her-and p53her-expressing clones from 20 to 24 separate transfections. To determine generation times, 2 Â 10 5 cells were seeded per 60-mm plate with or without b-estradiol, and cell numbers from duplicate dishes counted on 2 successive days. For functional analysis, b-estradiol (Sigma) was added to result in a final concentration of 1 mM (LLC-MK 2 ) and 200 nM (KMV) b-estradiol (Sigma).
Virus production and determination of interchromosomal recombination rates
Virus stocks were prepared by harvesting after calcium phosphate transfection of COS1 cells with the recombinant SV40 genomes. Low-titer virus supernatants were concentrated by use of a Minitan S ultrafiltration device (Millipore). Determination of viral titers via large tumor antigen immunofluorescence (multiplicity of infection, MOI) and via plaque assays (PFUs) was performed in CV1 cells as described (Wiesmu¨ller et al., 1996) .
Recombination assays with LLC-MK 2 (p53her), LLC-MK 2 [p53(138V)her], and LLC-MK 2 (neo) cells were executed and evaluated according to Dudenho¨ffer et al. (1998) . Each recombination frequency (n ¼ 1) used for calculating mean and s.e.m. values resembles the average value from four independent coinfections with the corresponding tsVP1(196Y) and tsVP1(290T) strains. To calculate the statistical significance of differences, we used Student's unpaired t-test.
Quantitative evaluation of de novo viral DNA synthesis
Cells on 60-mm plates were labeled with 30 mCi of [ 3 H]thymidine for 1 h, washed three times with PBS, and subjected to the Hirt procedure. Thus, cells were lysed with 600 ml of Hirt solution (20 mM Tris-HCl pH 7.4, 2 mM EDTA, 0.6% SDS) at room temperature (10 min), the lysate collected by centrifugation, mixed gently with 150 ml of 5 M NaCl, and incubated at 41C for at least 8 h. The low-molecular-weight DNA in Hirt supernatants was collected by centrifugation for 30 min at 41C, followed by RNAse and proteinase K treatment, phenol extraction, and ethanol precipitation. After resuspension in TE, [ 3 H]thymidine incorporation into the newly synthesized DNA was quantified by liquid scintillation counting of aliquots after trichloroacetic acid precipitation.
Fluorescence-based recombination measurements
Fluorescence-based recombination assays were performed as detailed previously (Akyu¨z et al., 2002) . Briefly, KMV cells were electroporated with a total amount of 20 mg DNA (HR-EGFP/3 0 EGFP-derived recombination plasmid plus p53 expression plasmid or pBS, 10 mg each). At 48 h after transfection, the percentages of green fluorescing cells were determined cytometrically by use of a Becton Dickinson Calibur FACScan. Transfection efficiencies were individually determined in triplicate after electroporation with a wtEGFP control plasmid and used to normalize each single recombination frequency.
DNA-binding analysis
As detailed by Akyu¨z et al. (2002) , we transiently transfected p53-negative KMV cells with pSV53her or pSVp53(138V)her to express p53her and p53(138V)her, respectively, and with pBS to serve as the control. Nuclear extracts were prepared as described by Dudenho¨ffer et al. (1998) . The RGC and the CTG98 fragments were 32 P-labeled by PCR amplification using the pUC-SV40-Cla construct containing the RGC and CTG98 repeat, respectively, and the primer pair 5 0 -AGGAGGA GATCTATCGATACCCGGGCAATTGTTGTTGTTAACT TGTTTATTG-3 0 /5 0 -AGTTAACAACAACAATTGCCCC-3 0 . Oligonucleotides and unincorporated nucleotides were removed by use of the QIAquick PCR purification kit (Qiagen, Hilden, FRG) according to the manufacturer's instructions. For the determination of DNA concentrations, we applied DNA Dipsticks (Invitrogen, Karlsruhe, FRG). The reaction mixture contained 25 mM Tris-HCl (pH 8.0), 5 mM EDTA, 1 mM DTT, 6% glycerol, 40 mM estradiol, 10 nM competitor tRNA, and 720 ng of the nuclear extract. For supershifting, 400 ng of DO1 (Calbiochem, Cambridge, MA, USA), directed against the N-terminal amino acids 21-25 of human p53, or alternatively 400 ng of BSA was included in the mixture, followed by a 30 min preincubation on ice. Subsequently, radioactively labeled DNA was added at a constant concentration of 0.1 nM. The final DNA binding mix was incubated at 391C for 30 min, electrophoresed on a native 4% polyacrylamide gel in 6.7 mM Tris-HCl (pH 8.0), 3.3 mM sodium acetate, and 2 mM EDTA at room temperature, and autoradiographed.
Immunoblot analysis
Protocols for the preparation of total cellular homogenates and Western blotting were as described by Dudenho¨ffer et al. (1999) . p53 was immunodetected by anti-p53 antibody DO1, p21 by anti-hp21 (Calbiochem), and actin by affinity-purified goat polyclonal antibody I-19 (Santa Cruz), coupled to recognition by affinity-purified and horseradish peroxidaseconjugated secondary IgGs (Biomol) and chemiluminescence enhancement by Super-Signal-ULTRA substrate (Pierce).
